Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy.
Open Access
- 1 October 1994
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 90 (4) , 1781-1785
- https://doi.org/10.1161/01.cir.90.4.1781
Abstract
BACKGROUND This study was performed to assess the initial results and long-term follow-up of Morrow septal myectomy for patients with hypertrophic obstructive cardiomyopathy (HOCM). METHODS AND RESULTS We studied 38 consecutive patients with HOCM (age, 13 to 74 years) who underwent a Morrow septal myectomy between 1977 and 1992. There were no perioperative deaths, and the postoperative course was uneventful for all except 2 of the patients. One patient required implantation of a pacemaker due to a complete heart block, and in 1 patient a small ventricular septal defect was caused. Follow-up (mean, 6.8 years) was 100% complete. No patient was reoperated for recurrent HOCM. All except 1 patient experienced a major functional improvement with a decrease of the mean New York Heart Association functional class from 3.0 before operation to 1.5 at follow-up (P < .001). Symptoms persisting during follow-up were angina pectoris in 3 of 22 patients (14%), dyspnea in 6 of 30 patients (20%), dizzy spells in 2 of 12 patients (17%), and syncope in 2 of 10 patients (20%). During follow-up no HOCM related death occurred. All patients were restudied by Doppler echocardiography. The peak gradient in the left ventricular outflow tract decreased from 72 +/- 30 mm Hg (range, 31 to 144 mm Hg) to 6 +/- 4 mm Hg (range, 0 to 20; P < .001). A systolic anterior movement was seen in 8 patients (21%) compared with 32 patients (97%) before the operation (P < .001). The left ventricular outflow tract diameter increased from 17 +/- 3 mm (range, 10 to 23 mm) to 22 +/- 3 mm (range, 15 to 33 mm; P < .001), and the mean subaortic septal thickness decreased from 23 +/- 5 mm (range, 15 to 35 mm) to 15 +/- 6 mm (range, 8 to 30 mm; P < .001). CONCLUSIONS Morrow septal myectomy for patients with HOCM is a safe procedure with an excellent clinical and Doppler echocardiographic long-term follow-up.Keywords
This publication has 15 references indexed in Scilit:
- Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathyThe American Journal of Cardiology, 1992
- Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: Clarification of pathophysiology and importance in intraoperative decision makingJournal of the American College of Cardiology, 1992
- Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathyThe Lancet, 1992
- Effect of left ventricular septal myectomy on concurrent mitral regurgitationThe Annals of Thoracic Surgery, 1989
- Aortic regurgitation: A common complication after surgery for hypertrophic obstructive cardiomyopathyJournal of the American College of Cardiology, 1989
- Mitral valve replacement in hypertrophic cardiomyopathy: Ten-year follow-up in 54 patientsThe American Journal of Cardiology, 1987
- Hypertrophic CardiomyopathyNew England Journal of Medicine, 1987
- Evaluation of aortic insufficiency by Doppler color flow mappingJournal of the American College of Cardiology, 1987
- Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic featuresThe American Journal of Cardiology, 1981
- PROGNOSIS AND MORTALITY OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHYThe Lancet, 1973